Modus Therapeutics @Modus_Tx
We're a Swedish biotech company developing #sevuparin for diseases with high unmet medical need, for patients with #sepsis and #septicshock. modustx.com Stockholm, Sweden Joined September 2021-
Tweets42
-
Followers18
-
Following68
-
Likes23
We look forward to presenting new data on #sevuparin at the @EHA_Hematology Congress, demonstrating its potential to treat hepcidin-related disorders such as #anemia in chronic kidney disease and other chronic inflammatory disorders. Click to read more: lnkd.in/eNdV3j_7
Our CEO is attending @LSXLeaders #WorldCongress in London this week. We look forward to discussing the progress of our lead candidate, sevuparin, with #lifescience leaders as we work towards initiating a Phase 2a study to evaluate #sevuparin as a potential treatment for #sepsis
We will join representatives from around the globe at the #WorldSepsisCongress 2023, where the theme is One Global Health Threat: #Sepsis, Pandemics, and Antimicrobial Resistance, to discuss the role of the emerging #technologies designed to treat and raise awareness of sepsis.
Our CEO is attending #BIOEuropeSpring this week to discuss the company's recent progress and the positive top-line data from our Phase 1b #clinicalstudy evaluating sevuparin as a potential new treatment for #sepsis, septic shock and other inflammatory diseases. #biopharma
Our CFO will attend DNB Nordic Healthcare Conference to discuss the potential of #sevuparin in treatment of #sepsis/septic shock, a serious and often fatal condition. Sevuparin is currently being evaluated in Phase 1b LPS provocation study, a well-established #clinical model.
Vad brinner vi för? Varför skall man investera i Modus? Vår VD, John Öhd, ger svar på relevanta frågor rörande Modus och vår utveckling av sevuparin för sepsis och septisk chock. youtu.be/JUAKu2ec0ZU #biotech #sepsis
Our CEO will give a company presentation at @EP_Access' Temadag: HealthCare following the successful completion of recruitment into its Phase 1b #clinical study evaluating sevuparin for treatment of #sepsis. Watch the Swedish presentation live here: youtu.be/cmYUVTBIFO0
Our CEO, John Öhd, will present at Stora Aktiedagen in Stockholm on 30 November to discuss Modus’ development of sevuparin for #sepsis and septic shock. Watch the Swedish presentation live at 14.30-15.00 CET: aktiespararna.se/tv/live #biotech
We're excited to be attending #BIOEurope in Leipzig, Germany this week to discuss recent progress in our Phase 1b trial investigating our lead asset, #sevuparin, for the treatment of #sepsis and #septicshock and learn about cutting-edge science in the #biotech space
Research in 2020 by @WHO_Europe_VPI revealed that 1 in 5 deaths worldwide are estimated to be due to #sepsis and septic shock. Watch to learn how #sevuparin could be a potential treatment to meet these diseases extremely high unmet need. #clinicaltrials youtube.com/watch?v=jblLlL…
We're thrilled to attend @NLifeScience Days on 29 September 2022. Meet with us to discuss the potential of #sevuparin to transform the treatment of #sepsis, #septicshock and other inflammatory diseases. #NLS2022 Click to register at NLS Days: nlsdays.com
In collaboration with @imperialcollege & @wellcometruste the SEVUSMART Phase 1 #clinical trial will evaluate #sevuparin in severe #malaria. This drug has already shown promising effects on the malaria parasite in patients with uncomplicated malaria modustx.com/press-release?…
We're now a proud signatory of @GlobalSepsis World Sepsis Declaration aiming to increase global, political and public awareness, to dramatically decrease the incidence of #sepsis by 2030 by improving #healthcare intervention and access to treatment #lifescience #support
Today is #WorldSepsisDay. Dedicated to providing new, improved #sepsis treatment, #clinical stage candidate #sevuparin is gearing up toward Ph2 trials. Sepsis affects approx. 49m globally each year, it's the no.1 cause for hospital readmissions & costs $22b a year in the US alone
As we approach #WorldSepsisDay, we remain focused on building awareness of #sepsis and its complications. We believe it's crucial to support the development of new treatment options as we progress #clinicaltrials for potential first-in-class therapy #sevuparin.
Our CFO, Claes Lindblad, will be presenting at @LSXLeaders Nordic Congress, 2022! We look forward to discussing the potential of #sevuparin as we move closer to finalising recruitment of its Phase 1b #clinicalstudy for treatment of #sepsis #sepsistreatment #sepsisawareness
This Wednesday we are attending Swiss Nordic Bio 2022! We look forward to discussing the development of #sevuparin for treatment of #sepsis with investors and other Nordic and Swiss #lifescience companies. Get in touch to arrange a meeting. swissnordicbio.com
Our lead product, #sevuparin is an innovative drug with a multimodal mechanism of action including anti-inflammatory & anticoagulation effects to treat #sepsis #sepsisshock & other inflammatory diseases. Click to read about our UK & US #clinicalresearch: modustx.com/sevuparin/abou…
2022 will be the most important year in our Company’s history! Having developed compound that can revolutionise the treatment of #sepsis, #sepsisshock and systematic inflamation, this year we initiate our pivotal Phase II #clinicalstudy for #sevuparin. carlsquare.com/analysuppdater…
Professor Johan von Schreeb has been named Head of KI’s Health Emergency and Pandemic Science Center. The aim is to find connections between groups and people and increase preparedness for a new pandemic or health crisis. news.ki.se/johan-von-schr…
David Fineberg, MD, M... @dfineberg
113 Followers 287 Following Clinical development of therapies for sepsis and septic shock
Ale Heu @ale_heu
0 Followers 2 Following
2o.5o.m @quarkglu0n
0 Followers 15 Following
DNA Script @DNAScript
2K Followers 1K Following Transforming how molecular biology translates to human health, personalized medicine and synthetic biology
Sami Muurimäki @SMuurimaki
25 Followers 196 Following
HEY GUYS @chuenkrathok
2 Followers 76 Following
Justin Case @gultefult
137 Followers 714 Following
The Biotech Analyst G... @analyst_biotech
1K Followers 138 Following Experienced investment group with focus on public Nordic biotech companies. We are currently focusing on companies in phase 3.
sicklecellnewsisfree! @sicklecellnews
5K Followers 4K Following Established in 2007/2008, we are the world's first magazine dedicated to SCD. Obtain your free copy at https://t.co/JBtevgOmwj
Ann-Louise Svensson @Annlo66
108 Followers 1K Following
DSI, a PLG Company @DSInPharmatics
237 Followers 2K Following DSI is a full service CMC Drug Development Consulting Firm, assisting emerging Biotech and Pharma sponsors with CMC, Regulatory and QA for NCEs & Biologics
40:40 Recruitment @4040rec
542 Followers 5K Following Specialist Recruitment Partner - Pharmaceutical & Healthcare arena #pharmaceutical #healthcare #medicaldevices #4040rec #medicalsales #marketresearch #uk
Dafo @foogerbrant
0 Followers 4 Following
Lysa Miller @lysapreneur
4K Followers 5K Following Entrepreneur, digital agency disruptor creating a hybrid agency model to meet the demands of tomorrow. Founder @metrowestwomen1
European Biotech @EuroBiotechNews
4K Followers 1K Following First and foremost in European biotech. European Biotechnology is your source for substantial information on the Life Science markets of Europe.
LifeSciencesBasel @FikazBasel
8 Followers 101 Following
MEDiSTRAVA, an Inizio... @MEDiSTRAVA_
1K Followers 2K Following
Global Sepsis Allianc... @GlobalSepsis
371 Followers 15 Following Non-profit charity organization Mission: Provide global leadership to reduce the worldwide burden of sepsis Initiator: World Sepsis Congress and @WorldSepsisDay
Asia Pacific Sepsis A... @AsianSepsis
99 Followers 21 Following #Sepsis is the most preventable cause of death and disability in the Asia Pacific Region - APSA is a coalition of Asia Pacific stakeholders out to change that!
Sepsisfonden @sepsisfonden
95 Followers 22 Following Sepsisfonden is a foundation engaged in fund-raising to aid sepsis research in Sweden as well as raising public awareness and knowledge around sepsis.
ActionOnSepsis @ActionOnSepsis
537 Followers 256 Following We are a UBC research excellence cluster that engages experts and the community to develop large-scale sepsis studies that transcend traditional research silos.
APIC @APIC
13K Followers 847 Following APIC: Improving health by preventing the spread of infection in healthcare settings through education and implementation of best practices.
Symbiosis Pharmaceuti... @SymbiosisPharma
1K Followers 399 Following Symbiosis Pharmaceutical Services is a leading GMP contract manufacturer of novel injectable pharmaceuticals for use in clinical trials.
Cytovale @Cytovale
252 Followers 185 Following Cytovale is pioneering an insightful new way to analyze immune cells and provide timely answers for sepsis and other immune-mediated diseases in under 10 min.
Abingworth @Abingworthbio
1K Followers 224 Following Abingworth is a leading transatlantic life sciences investment firm. Abingworth became part of Carlyle (NASDAQ: CG) on 1 August 2022.
@antabio @antabio
578 Followers 105 Following Developing Tomorrow’s #Antibacterials. #PoweredByCARBX. @allianceBEAM. #AntimicrobialResistance #AMR #CarbapenemResistance #NDM #OXA #KPC #CysticFibrosis #Lung
The UK Sepsis Trust @UKSepsisTrust
27K Followers 5K Following The UK's leading #sepsis charity, raising awareness and providing vital support to those affected by this life-threatening condition.
LifeSciencesBasel @FikazBasel
8 Followers 101 Following
UCR School of Medicin... @UCRSoM
2K Followers 60 Following Training physicians and developing programs to improve the health of all Californians. Follow us on Bluesky https://t.co/O17y3z6ACD
Direkt Börs @Borsredaktion
26K Followers 992 Following Börsredaktionen på Nyhetsbyrån Direkt @direktse Tipsa på: [email protected] och glöm inte att även följa @Makroredaktion
MEDiSTRAVA, an Inizio... @MEDiSTRAVA_
1K Followers 2K Following
Mandy Jackson @ScripMandy
6K Followers 758 Following I am Managing Editor, US Commercial News, for the Citeline Commercial publication Scrip. Views expressed here are strictly my own.
Scrip, Citeline Comme... @PharmaScrip
21K Followers 1K Following Scrip goes beyond the headlines to deliver insight & analysis on drug discovery, development and product life cycle value chain.
Swedish Biotech @BiotechSweden
3K Followers 2K Following Sweden's best biotech asset is its University Brainpower. That's why Sweden is emerging to be the next #Biotech Hotspot in the world! Follow for latest news!
Jessica Merrill @Jessicaemerrill
3K Followers 331 Following biopharma reporter, writer, reader, vermonter, mom.
ScanBalt BioRegion @ScanBalt
104 Followers 143 Following ScanBalt is Northern Europe’s Leading Accelerator for Inter-regional Cooperation envisioning the region as a Global Hotspot for Health and Bioeconomy
Brenda Sandburg @brendasandburg
578 Followers 227 Following Senior editor @pharmapinksheet @Pharma_Intell. Cover pharma regulatory, policy & legal issues. All views my own. https://t.co/1JTWH6UfEy
Karolinska Dev @Karolinska_Dev
1K Followers 3K Following Karolinska Development AB (SSE: KDEV) is an investment company focused on identifying medical innovation and supporting the creation and growth of companies
sicklecellnewsisfree! @sicklecellnews
5K Followers 4K Following Established in 2007/2008, we are the world's first magazine dedicated to SCD. Obtain your free copy at https://t.co/JBtevgOmwj
Arithmos @ARITHMOS_LS
2K Followers 4K Following Consulting, Technology and Services for #LifeSciences companies. Clinical, Regulatory, Quality, PV, Medical Affairs domains.
ola pihlblad @OlaPihlblad
17 Followers 174 Following
Jouko Ylä-Liedenpohj... @ylaliedenpohja
1K Followers 2K Following entinen kansantaloustieteen professori; formerly a professor of economics
STAT @statnews
165K Followers 5K Following Reporting from the frontiers of health & medicine. Sign up for any of our newsletters here: https://t.co/CBx3GZBv31
Megan Molteni @MeganMolteni
8K Followers 2K Following science writer @statnews | formerly @WIRED | she/her | genetic privacy & Crispr tips to [email protected] | DM for signal
Informa Connect @InformaConnect
2K Followers 1K Following Live events, digital content and training for professionals who want to achieve more. Click the link in our profile to find out more:
World Sepsis Day @WorldSepsisDay
13K Followers 827 Following Every 2.8 seconds someone dies of #sepsis. We want to change this. News, updates, and insights on #WorldSepsisDay, #WorldSepsisCongress, and the WSD Movement.
Sedermera Corporate F... @SedermeraCF
2K Followers 963 Following Med hög etisk kompass erbjuder vi kapitaliseringar och noteringar samt tjänster för noterade bolag. Varmt välkomna att kontakta oss!
Imperial College Lond... @imperialcollege
187K Followers 3K Following A global top-ten university, where scientific imagination leads to world-changing impact. Science | Engineering | Medicine | Business #OurImperial 💙
Kathryn Maitland @KathMaitland
1K Followers 188 Following
Citeline @Citeline
4K Followers 1K Following Trusted by the top 50 pharma companies and top 10 CROs — delivering real‑time clinical, regulatory & competitive intelligence to support faster, smarter decisio
Jonathan Smith @j_ivories
374 Followers 507 Following Reporter for @labiotech_eu. #Data visualisation and #locust nerd. Language learner. #scififantasy fan, #scicomm #PhD
DNA Script @DNAScript
2K Followers 1K Following Transforming how molecular biology translates to human health, personalized medicine and synthetic biology
MedNous @MedNous
513 Followers 371 Following A monthly publication providing critical insights into the business of medical innovation in Europe. Published in London, distributed by subscription worldwide.
Clive Cookson @clivecookson
5K Followers 299 Following Senior science writer, Financial Times. All views are mine or borrowed from other people — and not necessarily the FT's.
European Biotech @EuroBiotechNews
4K Followers 1K Following First and foremost in European biotech. European Biotechnology is your source for substantial information on the Life Science markets of Europe.
EBD Group @EBDgroup
5K Followers 4K Following Official Twitter account of EBD Group, the leading partnering firm for the global life science industry.
Forska!Sverige @forskasverige
3K Followers 433 Following Forska!Sverige är en oberoende stiftelse som verkar för att förbättra villkoren för medicinsk forskning och dess tillämpning.
SwedenBIO @SwedenBIO
2K Followers 488 Following We're the industry association for Swedish life science, working to support a vibrant and innovative life science arena in Sweden and beyond.
Nordic Life Science @NLifeScience
901 Followers 109 Following Join us for daily news and stories from the Nordic life science industry.
Pink Sheet @PharmaPinkSheet
6K Followers 328 Following Pink Sheet delivers analysis & commentary focused on regulatory implications, including high value perspectives from insiders & thought leaders across the globe
Karolinska Institutet @karolinskainst
40K Followers 173 Following The account has been deactivated. For news about research, visit https://t.co/v49jIndTNs.
Mats Wahlgren @wahlgren_mats
6 Followers 1 Following Professor Karolinska Institutet I study malaria to alleviate poverty
Amber Tong @AmberTongPW
4K Followers 991 Following Covering China biotech and pharma @business | formerly @endpts | views are my own | say hi: [email protected]
Hannah Kuchler @hannahkuchler
19K Followers 5K Following Global pharma editor @FT, leading science and pharma team. Emmy-nominated, Loeb winner. Previously NY, SF, HK.You might like
